VL-Medi Oy
About VL-Medi Oy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Estetra
1
VL-Medi Oy
1
Clinical Trials at VL-Medi Oy
During the past decade, VL-Medi Oy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?
2011-09-01
Unknown status
90
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
2017-07-31
2021-10-25
Completed
766
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
2018-07-04
2020-11-26
Terminated
8
Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents
2020-12-28
2023-12-01
Active, not recruiting
145
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "VL-Medi Oy"
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at VL-Medi Oy
According to Clinical.Site data, the most researched conditions in "VL-Medi Oy" are
"Bleeding" (1 trials), "Endometriosis" (1 trials), "Safety" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "VL-Medi Oy" in a lesser frequency.
Clinical Trials Intervention Types at VL-Medi Oy
Most popular intervention types in "VL-Medi Oy" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Vilaprisan (BAY1002670)" (2 trials), "Desogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon)" (1 trials), "E4/DRSP 15/3 mg combined tablet" (1 trials), "Etonogestrel 68 mg subdermal implant" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at VL-Medi Oy
The vast majority of trials in "VL-Medi Oy" are
4 trials for "Female" genders.
Clinical Trials Status at VL-Medi Oy
Currently, there are NaN active trials in "VL-Medi Oy".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in VL-Medi Oy,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in VL-Medi Oy, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".